All Pharma articles – Page 3
-
News
Health leaders hit out at firms for continuing Russia links
Simon Stevens and Jeremy Hunt have hit out at companies with NHS links which continue to trade with Russia.
-
HSJ Partners
Connected medication management – How can BD help make it a reality?
Medication errors harm patients and cost the NHS money – but with the right approach they can be significantly reduced. A 2018 study from researchers at York, Manchester and Sheffield universities found that there were likely to be 237 million medication errors a year in the NHS and this could ...
-
Comment
The secret weapon that could help win the PM’s war on cancer
Andrew M Wardley says there is one intervention that can both help catch cancer earlier and reduce health inequalities in cancer care: expanding outreach cancer services
-
HSJ Partners
More than skin deep – understanding the burden of psoriasis and psoriatic arthritis (PsA)
Focusing on psoriasis could help to manage costly comorbidities, policymakers told
-
HSJ Partners
Tackling covid-related challenges in services for patients with respiratory conditions
The covid pandemic has created challenges for many NHS services, including those dealing with patients with respiratory conditions. Sponsored by A webinar, sponsored by Boehringer Ingelheim, at HSJ’s virtual respiratory forum looked at the impact on services for patients with idiopathic pulmonary fibrosis and how these could be ...
-
News
Technology ‘tsunami’ creates funding challenge, says regulator chief
The ‘tsunami’ of digital health technologies being adopted by the NHS is putting a strain on regulators’ ability to determine which ones offer value for money, according to outgoing National Institute for Health and Care Excellence chief executive Gill Leng.
-
News
Insurance boss named NICE chief executive
Samantha Roberts, the managing director of insurance provider Legal and General’s health and care business, is to become the chief executive of the National Institute for Health and Care Excellence.
-
HSJ Partners
Clinical spotlight – What do emerging treatments for cancer tell us about how the NHS can best adopt and spread innovation?
This is paid-for content from our commercial partners. Find out more This article was organised and fully funded by Bristol Myers Squibb, as a follow-up to a roundtable hosted in collaboration with HSJ. Bristol Myers Squibb has not determined the content of the ...
-
HSJ Interactive
How can we improve medication safety?
An HSJ roundtable, in association with BD, looked at what has been done to reduce risk of harm from medicines, and what the next steps of progress could be
-
News
Health secretary to act on racial bias in effectiveness of medical devices
Sajid Javid has said medical device manufacturers should check their products work well for people of all ethnic backgrounds, citing problems that those with dark skin have experienced when using pulse oximeters.
-
HSJ Awards
HSJ Patient Safety Awards 2021:Improving Safety in Medicines Management Award
Partnered by WINNER: Royal Surrey FT: St Luke’s Cancer Centre and Pharmacy Team Delivery of Safe Systemic Anti-Cancer Treatment During the Covid-19 Pandemic
-
HSJ Partners
Clinical engagement in service development holds the key to embedding innovation in cancer services
This is paid-for content from our commercial partners. Find out more This article was organised and fully funded by Bristol Myers Squibb, and developed in collaboration by BMS and HSJ. This article has no promotional intent. Bristol-Myers Squibb does not intend to encourage the use ...
-
HSJ Partners
How much does osteoarthritis-related pain cost the NHS?
This is paid-for content from our commercial partners. Find out more Sponsored by This article has been commissioned and funded by Pfizer Limited. The impact of osteoarthritis (OA)-related pain goes far beyond patients and the people closest to them. ...
-
HSJ Awards
HSJ Value Awards 2021: Pharmacy and Medicines Optimisation Award
WINNER: Northern Devon Healthcare Trust: Medicines Optimisation in Orthopaedic Enhanced Recovery The pharmacy department of a district general hospital worked with the multidisciplinary team in orthopaedics to reduce variation in medication use among elective hip and knee replacement patients. The project focused on the following points to optimise medication use: ...
-
News
Interim chief commercial officer chosen by NHS England
The NHS’ ‘chief negotiator with the pharmaceutical industry’ has been made interim chief commercial officer after the incumbent CCO left to head up Downing Street’s new delivery unit.
-
News
Group set up by govt review flags ‘culture of protect and deny’
A “systemic culture of protect and deny” in government means many more women and children will be harmed through poor care, according to the co-chair of an official patient group set up to review medical devices.
-
News
NHSE confirms consultation on mandatory staff covid vaccination
The number of pharmacies delivering the covid-19 vaccination is set to more than double for the planned autumn booster campaign, new guidance states.
-
HSJ Local
Critical report on leading trust watered down ‘on an industrial scale’
Findings included in a draft report which were strongly critical of a prominent cancer trust were extensively deleted or softened before publication, HSJ has discovered.
-
Comment
New regulation will balance safety and innovation
If the UK is to maintain its position as a champion of life sciences, its new regulatory regime must find the middle ground between safety and innovation, notes Lord Ara Darzi
-
Expert Briefing
North by North West: The tough questions NHSE must answer over famous cancer trust
Essential insight into NHS matters in the North West of England. Contact me in confidence here.